Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021
This study revealed that the global disease burden of MDR-TB increased from 1990 to 2021 and is predicted to grow till 2050. Disparities among different social-demographic regions were remarkable and extended over time. Epidemiological changes contributed most to the escalated disease burden. Targeted public health strategies should be adopted for patients in specific regions and age groups.
Authors
- Anquan Shang (ORCID: https://orcid.org/0000-0003-2820-1982)
- Yuan Jiang (ORCID: https://orcid.org/0000-0003-1211-6812)
- Lili Wang (ORCID: https://orcid.org/0000-0002-6559-9910)
- Xinyue Wang (ORCID: https://orcid.org/0000-0002-8634-9590)
- Fenyong Sun
- Haowei Chen (ORCID: https://orcid.org/0000-0003-1466-5348)
- Chaoyan Yue (ORCID: https://orcid.org/0000-0002-0597-8388)
- Huijuan Li (ORCID: https://orcid.org/0000-0002-5542-9950)
- Shutao Qiu
Institutions
- Xuzhou Medical College (CN)
- Lianyungang Oriental Hospital (CN)
- Zhujiang Hospital (CN)
- The First People’s Hospital of Lianyungang (CN)
- Shanghai Tenth People's Hospital (CN)
- Obstetrics and Gynecology Hospital of Fudan University (CN)
- Shanghai Municipal Center For Disease Control Prevention (CN)
Publication Details
- Journal
- Drug Resistance Updates
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1016/j.drup.2025.101265
- Citations
- 15
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 20.94
Funders
- Shanghai Municipal Health Commission
- Jiangsu Commission of Health
- National Natural Science Foundation of China
- Shanghai Municipal Health Bureau
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission